The current valuation score of Verastem Inc is 6.10, ranking 357 out of 386 in the Biotechnology & Medical Research industry. Its current P/E ratio is -2.50, which is -72.92% below the recent high of -0.68 and -42.11% above the recent low of -3.55.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.